Previous Close | 69.67 |
Open | 69.94 |
Bid | 0.00 x 1000 |
Ask | 0.00 x 800 |
Day's Range | 69.50 - 70.84 |
52 Week Range | 52.90 - 75.31 |
Volume | |
Avg. Volume | 248,817 |
Market Cap | 3.466B |
Beta (5Y Monthly) | 0.53 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.61 |
Earnings Date | May 02, 2024 - May 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Dec 27, 2013 |
1y Target Est | 75.60 |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The nausea-fighting brand is highlighting the cultural impact of barf bags and ushering them into a new era with a documentary, a limited-edition collection of upcycled bags and a custom wearable art piece made from vintage bagsTARRYTOWN, N.Y., April 03, 2024 (GLOBE NEWSWIRE) -- 1949 was a big year for barf, welcoming the invention of the barf bag and Dramamine®. Seventy-five years later, Dramamine, a Prestige Consumer Healthcare brand, thrives as the number one brand for motion sickness relief,
Key Insights The projected fair value for Prestige Consumer Healthcare is US$143 based on 2 Stage Free Cash Flow to...